Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Detection of bacterial biofilms using covalent lectin binders


HIPS researchers produced a molecule that provides a way to visualise Pseudomonas infections

Pseudomonas aeruginosa is a major pathogen that can cause severe infections in various organs of the human body. The infection becomes particularly harmful when the bacteria agglomerate into biofilms: They do this not only to evade attacks of the immune system, but also to protect themselves from the effects of antibiotics. This results in chronic infections that are almost impossible to treat.

Biofilm of a clinical isolate of Pseudomonas aeruginosa stained with fluorescent dyes (green: living cells; red: dead cells)

TWINCORE/Janne Thöming

Scientists from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a joint branch of the Helmholtz Centre for Infection Research (HZI) and Saarland University, developed a molecule, which binds specifically and irreversibly to a key bacterial protein in biofilms.

By binding, this molecule blocks an important component of the biofilm and can also visualise the biofilm, when it is labelled with an appropriate dye. The scientists published their results in the international edition of Angewandte Chemie.

Bacteria of the Pseudomonas aeruginosa species are hospital germs and are resistant to many common antibiotics. They can infect all organs and implants and form so-called biofilms, in which they are protected and survive for long periods of time. This results in a chronic infection that is very difficult to treat, since both the immune system and antibiotics cannot harm the bacteria.

To produce a biofilm, Pseudomonas bacteria release certain proteins called lectins. These proteins bind to sugar molecules outside the bacterial cells and cross-link them to form a matrix, in which the pathogens agglomerate. If it was possible to block these lectins with an agent, existing biofilms could be dissolved or the production of biofilms could be prevented altogether.

Since, for instance, the lectin called "LecA" binds sugar molecules only relatively loosely, the HIPS researchers directed by Dr Alexander Titz imparted on a search for a molecule that permanently binds to LecA. This requires a so-called covalent bond or atomic bond. "Initially, we used X-ray structural analysis to analyse the three-dimensional structure of LecA and then we rationally designed a small molecule, whose properties should allow it to form a covalent bond to the sugar binding site of LecA," says Alexander Titz.

After designing this molecule, the researchers then produced it by synthesis in the laboratory and exposed it to LecA. Using a variety of biophysical methods, their collaboration partners at the HIPS and the Centre national de la recherche scientifique in Grenoble were able to prove the exact position of the binding site on the lectin. Using mass spectrometry, they were able to unequivocally demonstrate covalent binding.

"This is the first time a specific molecule was produced that binds covalently to a lectin," says Titz, who is the head of the "Chemical Biology of Carbohydrates" junior research group of the HZI and the German Center for Infection Research. One possible approach to an application is to develop the molecule into an agent that suppresses biofilm production in Pseudomonas aeruginosa.

The bacteria would then grow normally, but would no longer produce a biofilm and would be much less hazardous – since they lose their virulence. They would then be susceptible to treatment with antibiotics, if they are not eliminated earlier by the immune system. However, the new molecule still needs to be optimised more for this approach as a pathogenicity blocker.

"We already demonstrated another application, though, namely in imaging," says Alexander Titz. "We coupled the lectin-binding molecule to a fluorescent dye and were able to visualise existing biofilms." To date, a diagnosis of a Pseudomonas aeruginosa infection can be made, but the exact site of the infection in the body is often difficult to determine. As a result the therapy cannot be directed specifically at the affected organ or tissue.

"We still need to develop the molecule further for diagnostic application in humans. For example, instead of the fluorescence dye, we need to use a probe that facilitates detection by magnetic resonance or positron emission tomography," says Titz. In addition, the long-term survival of the molecule in the body needs to be assured. These optimisation processes are ongoing in the scope of funding from the European Research Council (ERC).

Original publication:
Stefanie Wagner, Dirk Hauck, Michael Hoffmann, Roman Sommer, Ines Joachim, Rolf Müller, Anne Imberty, Annabelle Varrot, Alexander Titz: Covalent lectin inhibition and application in bacterial biofilm imaging. Angewandte Chemie International Edition, 2017. DOI: 10.1002/anie.201709368

The press release and a picture are also available on our website:

Helmholtz Centre for Infection Research:
Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, are engaged in the study of different mechanisms of infection and of the body’s response to infection. Helping to improve the scientific community’s understanding of a given bacterium’s or virus’ pathogenicity is key to developing effective new treatments and vaccines.

German Center for Infection Research:
At the German Center for Infection Research (DZIF), about 500 scientists from 35 institutions nationwide jointly develop new approaches for the prevention, diagnosis and treatment of infectious diseases. Their aim is to translate research results into clinical practice rapidly and effectively. With this, the DZIF paves the way for developing new vaccines, diagnostics and drugs in the fight against infections. Further information at:

Susanne Thiele, Press Officer
Dr Andreas Fischer, Editor

Helmholtz Centre for Infection Research
Press and Communications
Inhoffenstr. 7
D-38124 Braunschweig

Phone: +49 531 6181-1404

Susanne Thiele | Helmholtz-Zentrum für Infektionsforschung

More articles from Life Sciences:

nachricht Make way for the mini flying machines
21.03.2018 | American Chemical Society

nachricht New 4-D printer could reshape the world we live in
21.03.2018 | American Chemical Society

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

TRAPPIST-1 planets provide clues to the nature of habitable worlds

21.03.2018 | Physics and Astronomy

The search for dark matter widens

21.03.2018 | Materials Sciences

Natural enemies reduce pesticide use

21.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>